Old Web
English
Sign In
Acemap
>
Paper
>
TMC278 (Rilpivirine): A Next‐Generation NNRTI in Phase III Clinical Development for Treatment‐Naive Patients
TMC278 (Rilpivirine): A Next‐Generation NNRTI in Phase III Clinical Development for Treatment‐Naive Patients
2011
Jérôme Emile Georges Guillemont
Katia Boven
Herta Crauwels
Marie-Pierre de Béthune
Keywords:
Rilpivirine
Virology
Medicine
therapy naive
Correction
Source
Cite
Save
Machine Reading By IdeaReader
32
References
0
Citations
NaN
KQI
[]